AML typical mutations (CEBPA, FLT3, and NPM1) identify a high-risk CMML independent of CPSS-Mol classification Blood Adv
Leveraging interdisciplinary management in people with HIV and lymphoid neoplasms J ANTIMICROB CHEMOTH
Efficacy and safety of fedratinib in patients with myelofibrosis previously treated with ruxolitinib (FREEDOM2): results from a multicentre, open-label, randomised, controlled, phase 3 trial Lancet Haematol
Genome-wide integrated DNA methylome and transcriptome analysis reveals a strong dysregulated myeloid component in the epigenetic landscape of Systemic Sclerosis Arthritis Rheumatol
Estimating cure and risk of death from other causes of cancer patients: EUROCARE-6 data on head & neck, colorectal, and breast cancers Eur J Cancer
CLL crosstalk with naïve T cells enhances the differentiation of IL-22-producing T cells and CLL -cell survival Leukemia
Histone variant macroH2A1 regulates synchronous firing of replication origins in the inactive X chromosome Nucleic Acids Res
Reduced Dose of Post-Transplant Cyclophosphamide with Tacrolimus for the Prevention of Graft-versus-Host Disease in HLA-Matched Donor Peripheral Blood Stem Cell Transplants: A Prospective Pilot Study Cancers